Analysing molecular polar surface descriptors to predict blood-brain barrier permeation
暂无分享,去创建一个
Thomas Dandekar | Sergey Shityakov | Carola Förster | Winfried Neuhaus | T. Dandekar | C. Förster | S. Shityakov | W. Neuhaus
[1] Xi Chen,et al. THE IMPACT OF P-GLYCOPROTEIN ON THE DISPOSITION OF DRUGS TARGETED FOR INDICATIONS OF THE CENTRAL NERVOUS SYSTEM: EVALUATION USING THE MDR1A/1B KNOCKOUT MOUSE MODEL , 2005, Drug Metabolism and Disposition.
[2] W. Geldenhuys,et al. 3-D-QSAR and docking studies on the neuronal choline transporter. , 2010, Bioorganic & medicinal chemistry letters.
[3] Kazuhiko Yanai,et al. In vivo evaluation of P-glycoprotein modulation of 8 PET radioligands used clinically. , 2007, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[4] B Testa,et al. Predicting blood-brain barrier permeation from three-dimensional molecular structure. , 2000, Journal of medicinal chemistry.
[5] J. Baron,et al. A comprehensive investigation of plasma and brain regional pharmacokinetics of imipramine and its metabolites during and after chronic administration in the rat. , 1996, Journal of pharmaceutical sciences.
[6] Ulf Norinder,et al. Prediction of Polar Surface Area and Drug Transport Processes Using Simple Parameters and PLS Statistics. , 2001 .
[7] D. Kroetz,et al. Human liver carbamazepine metabolism. Role of CYP3A4 and CYP2C8 in 10,11-epoxide formation. , 1994, Biochemical pharmacology.
[8] E. Spina,et al. ABCB1 Polymorphisms Influence Steady-State Plasma Levels of 9-Hydroxyrisperidone and Risperidone Active Moiety , 2008, Therapeutic drug monitoring.
[9] Kristina Luthman,et al. Polar Molecular Surface Properties Predict the Intestinal Absorption of Drugs in Humans , 1997, Pharmaceutical Research.
[10] Hyosub E. Kim,et al. A Comparative Study of Successful Central Nervous System Drugs Using Molecular Modeling , 2011 .
[11] N. Nachtrieb,et al. Principles of Modern Chemistry , 1986 .
[12] Nipa Shah,et al. Biopharmaceutics classification system: validation and learnings of an in vitro permeability assay. , 2009, Molecular pharmaceutics.
[13] J. Donovan,et al. The brain entry of risperidone and 9-hydroxyrisperidone is greatly limited by P-glycoprotein. , 2004, The international journal of neuropsychopharmacology.
[14] W. Pardridge,et al. Drug Transport across the Blood–Brain Barrier , 2012, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[15] M Pastor,et al. VolSurf: a new tool for the pharmacokinetic optimization of lead compounds. , 2000, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[16] R Griffiths,et al. Development of a new physicochemical model for brain penetration and its application to the design of centrally acting H2 receptor histamine antagonists. , 1988, Journal of medicinal chemistry.
[17] Bernard Testa,et al. A simple model to predict blood-brain barrier permeation from 3D molecular fields. , 2002, Biochimica et biophysica acta.
[18] M. Ingelman-Sundberg,et al. Substrate specific metabolism by polymorphic cytochrome P450 2D6 alleles. , 2005, Toxicology in vitro : an international journal published in association with BIBRA.
[19] Imre G. Csizmadia,et al. Theory and Practice of MO Calculations on Organic Molecules , 1976 .
[20] G. Fricker. Drug transport across the blood-brain barrier. , 2002, Ernst Schering Research Foundation workshop.
[21] Guo-Ping Wang,et al. Predicting blood-brain barrier penetration from molecular weight and number of polar atoms. , 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[22] P. Selzer,et al. Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties. , 2000, Journal of medicinal chemistry.
[23] M. Dove. An introduction to atomistic simulation methods , 2008 .
[24] Denis M. Bayada,et al. Polar Molecular Surface as a Dominating Determinant for Oral Absorption and Brain Penetration of Drugs , 1999, Pharmaceutical Research.
[25] M. Ebinger,et al. Blood-brain barrier penetration and pharmacokinetics of amitriptyline and its metabolites in p-glycoprotein (abcb1ab) knock-out mice and controls. , 2007, Journal of psychiatric research.
[26] D. E. Clark. Rapid calculation of polar molecular surface area and its application to the prediction of transport phenomena. 1. Prediction of intestinal absorption. , 1999, Journal of pharmaceutical sciences.
[27] R. J. Doerksen,et al. Topological polar surface area: a useful descriptor in 2D-QSAR. , 2009, Current medicinal chemistry.
[28] A. Leo,et al. Hydrophobicity and central nervous system agents: on the principle of minimal hydrophobicity in drug design. , 1987, Journal of pharmaceutical sciences.
[29] Zeruesenay Desta,et al. Characterization of human cytochrome P450 enzymes catalyzing domperidone N-dealkylation and hydroxylation in vitro. , 2004, British journal of clinical pharmacology.
[30] D. E. Clark,et al. Rapid calculation of polar molecular surface area and its application to the prediction of transport phenomena. 2. Prediction of blood-brain barrier penetration. , 1999, Journal of pharmaceutical sciences.
[31] D. Greenblatt,et al. Metabolism of the antidepressant mirtazapine in vitro: contribution of cytochromes P-450 1A2, 2D6, and 3A4. , 2000, Drug metabolism and disposition: the biological fate of chemicals.
[32] Yuichi Sugiyama,et al. Impact of Drug Transporter Studies on Drug Discovery and Development , 2003, Pharmacological Reviews.
[33] C. Ebert,et al. Volsurf computational method applied to the prediction of stability of thermostable enzymes. , 2007, Biotechnology journal.
[34] Warren J. Hehre,et al. A Guide to Molecular Mechanics and Quantum Chemical Calculations , 2003 .
[35] Colin D. A. Brown,et al. Mediation of cimetidine secretion by P‐glycoprotein and a novel H+‐coupled mechanism in cultured renal epithelial monolayers of LLC‐PK1 cells , 1996, British journal of pharmacology.
[36] L. Rubin,et al. Occludin as a possible determinant of tight junction permeability in endothelial cells. , 1997, Journal of cell science.
[37] M. Pirmohamed,et al. Carbamazepine is not a substrate for P-glycoprotein. , 2001, British journal of clinical pharmacology.
[38] R. H. Petrucci,et al. General Chemistry: Principles and Modern Applications , 1972 .
[39] W. Löscher,et al. Differences in the transport of the antiepileptic drugs phenytoin, levetiracetam and carbamazepine by human and mouse P-glycoprotein , 2007, Neuropharmacology.